X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21570) 21570
Book Review (4969) 4969
Publication (925) 925
Magazine Article (309) 309
Book / eBook (305) 305
Book Chapter (143) 143
Newsletter (60) 60
Conference Proceeding (59) 59
Newspaper Article (34) 34
Dissertation (14) 14
Trade Publication Article (7) 7
Web Resource (6) 6
Paper (4) 4
Patent (4) 4
Data Set (3) 3
Government Document (2) 2
Journal / eJournal (1) 1
Reference (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (16115) 16115
humans (15051) 15051
administration, oral (8043) 8043
female (7809) 7809
male (7460) 7460
warfarin (5181) 5181
aged (4943) 4943
anticoagulants - administration & dosage (4937) 4937
middle aged (4911) 4911
anticoagulants (4730) 4730
anticoagulants - therapeutic use (4547) 4547
adult (3891) 3891
atrial fibrillation (3549) 3549
risk factors (3473) 3473
anticoagulants - adverse effects (3382) 3382
hematology (3261) 3261
peripheral vascular disease (2896) 2896
stroke (2680) 2680
treatment outcome (2651) 2651
cardiac & cardiovascular systems (2646) 2646
oral anticoagulants (2612) 2612
pharmacology & pharmacy (2466) 2466
dabigatran (2414) 2414
abridged index medicus (2335) 2335
rivaroxaban (2240) 2240
aged, 80 and over (2233) 2233
animals (2139) 2139
thromboembolism (2124) 2124
venous thromboembolism (2123) 2123
atrial fibrillation - drug therapy (2108) 2108
risk (2062) 2062
prevention (2044) 2044
therapy (2035) 2035
management (1980) 1980
oral anticoagulation (1876) 1876
hemorrhage - chemically induced (1865) 1865
medicine, general & internal (1852) 1852
dentistry (1809) 1809
atrial-fibrillation (1753) 1753
surgery (1735) 1735
stroke - prevention & control (1704) 1704
international normalized ratio (1694) 1694
thrombosis (1647) 1647
analysis (1564) 1564
atrial fibrillation - complications (1549) 1549
warfarin - therapeutic use (1514) 1514
time factors (1499) 1499
dentistry, oral surgery & medicine (1483) 1483
anticoagulation (1481) 1481
care and treatment (1478) 1478
warfarin - administration & dosage (1448) 1448
medicine & public health (1384) 1384
retrospective studies (1372) 1372
apixaban (1346) 1346
oral anticoagulant-therapy (1206) 1206
warfarin - adverse effects (1198) 1198
drug therapy (1191) 1191
adolescent (1177) 1177
safety (1177) 1177
bleeding (1161) 1161
dose-response relationship, drug (1161) 1161
risk assessment (1150) 1150
thromboembolism - prevention & control (1149) 1149
health aspects (1125) 1125
stroke prevention (1121) 1121
prospective studies (1109) 1109
antithrombotic therapy (1071) 1071
deep-vein thrombosis (1053) 1053
aspirin (1043) 1043
blood coagulation - drug effects (1039) 1039
follow-up studies (1026) 1026
patients (1021) 1021
direct oral anticoagulants (1020) 1020
vitamin k - antagonists & inhibitors (1010) 1010
stroke - etiology (1007) 1007
hemorrhage (985) 985
pharmacokinetics (975) 975
research (960) 960
mortality (953) 953
internal medicine (922) 922
molecular-weight heparin (922) 922
rats (903) 903
cardiology (872) 872
anticoagulants - pharmacology (868) 868
cardiac arrhythmia (859) 859
prothrombin time (846) 846
risk-factors (844) 844
young adult (839) 839
dosage and administration (831) 831
metaanalysis (831) 831
drug interactions (801) 801
drug administration schedule (797) 797
efficacy (792) 792
thrombin (788) 788
clinical trials (749) 749
venous thrombosis (725) 725
medical research (717) 717
oral contraceptives (713) 713
randomized controlled trials as topic (677) 677
pregnancy (676) 676
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
UTL at Downsview - May be requested (159) 159
Dentistry (Harry R Abbott) - Stacks (81) 81
Gerstein Science - Stacks (51) 51
Dentistry (Harry R Abbott) - Withdrawn (50) 50
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (33) 33
Collection Dvlpm't (Acquisitions) - Closed Orders (10) 10
Dentistry (Harry R Abbott) - Circulation Desk (7) 7
Online Resources - Online (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Dentistry (Harry R Abbott) - May be requested (5) 5
Dentistry (Harry R Abbott) - Searching (3) 3
Lakeridge Health Sciences - Oshawa (3) 3
Robarts - Stacks (3) 3
Scarborough Hospital - Birchmount (2) 2
St. Michael's Hospital - Stacks (2) 2
UofT at Mississauga - Stacks (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Dentistry (Harry R Abbott) - Course Reserves (1) 1
Dentistry (Harry R Abbott) - Mending (1) 1
Dentistry (Harry R Abbott) - Missing (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
New College (Ivey) - Stacks (1) 1
Regis College - Stacks (1) 1
Royal Ontario Museum - Reference (1) 1
Scarborough Hospital - General (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - Withdrawn (1) 1
University College (Laidlaw) - May be requested in 6-10 wks (1) 1
UofT at Scarborough - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (20149) 20149
German (674) 674
French (422) 422
Spanish (404) 404
Italian (161) 161
Russian (137) 137
Japanese (88) 88
Portuguese (87) 87
Polish (73) 73
Hungarian (45) 45
Czech (20) 20
Danish (20) 20
Turkish (20) 20
Dutch (18) 18
Chinese (15) 15
Norwegian (15) 15
Swedish (14) 14
Korean (12) 12
Arabic (8) 8
Hebrew (8) 8
Bulgarian (6) 6
Finnish (6) 6
Serbian (6) 6
Croatian (5) 5
Slovenian (5) 5
Romanian (4) 4
Lithuanian (2) 2
Bosnian (1) 1
Estonian (1) 1
Georgian (1) 1
Icelandic (1) 1
Persian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Heart Journal, ISSN 0002-8703, 2016, Volume 182, pp. 28 - 35
Background Non-vitamin K antagonist oral anticoagulants (NOACs, dabigatran, rivaroxaban, apixaban, and edoxaban) have been increasingly used as alternatives to... 
Cardiovascular | INTRAVENOUS THROMBOLYSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | DABIGATRAN ANTICOAGULATION | TISSUE-PLASMINOGEN ACTIVATOR | WARFARIN | ACUTE ISCHEMIC-STROKE | GUIDELINES | INTRACEREBRAL HEMORRHAGE | RISK SCORE | HEALTH-CARE PROFESSIONALS | INTRACRANIAL HEMORRHAGE | United States - epidemiology | Dabigatran - adverse effects | Dabigatran - administration & dosage | Anticoagulants - administration & dosage | Humans | Stroke - diagnosis | Warfarin - adverse effects | Male | Thiazoles - administration & dosage | Antithrombins - administration & dosage | Medication Therapy Management - standards | Warfarin - administration & dosage | Rivaroxaban - administration & dosage | Thiazoles - adverse effects | Pyridones - administration & dosage | Pyridines - adverse effects | Rivaroxaban - adverse effects | Adult | Female | Registries | Stroke - therapy | Pyrazoles - adverse effects | Stroke - prevention & control | Pyridines - administration & dosage | Administration, Oral | Atrial Fibrillation - drug therapy | Atrial Fibrillation - complications | Emergency Treatment - methods | Anticoagulants - adverse effects | Outcome and Process Assessment (Health Care) | Pyrazoles - administration & dosage | Stroke - etiology | Quality Improvement | Antithrombins - adverse effects | Emergency Treatment - mortality | Pyridones - adverse effects | Cohort Studies | Stroke (Disease) | Warfarin | Diet therapy | Stroke patients | Atrial fibrillation | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2008, Volume 51, Issue 8, pp. 818 - 825
Journal Article
1996, ISBN 0340552662, vii, 280
Book
American Journal of Medicine, The, ISSN 0002-9343, 2014, Volume 127, Issue 11, pp. 1075 - 1082.e1
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2015, Volume 128, Issue 12, pp. 1300 - 1305.e2
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 23, pp. 2779 - 2790
Abstract Background Dose reduction of non–vitamin K antagonist oral anticoagulants (NOACs) is indicated in patients with atrial fibrillation (AF) with renal... 
Cardiovascular | Internal Medicine | kidney disease | dose | bleeding | embolism | stroke | CARDIAC & CARDIOVASCULAR SYSTEMS | SAFETY | RIVAROXABAN | RISK | APIXABAN | MDRD | CARE | COCKCROFT-GAULT | DABIGATRAN | WARFARIN | United States - epidemiology | Dabigatran - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Male | Antithrombins - administration & dosage | Rivaroxaban - administration & dosage | Factor Xa Inhibitors - administration & dosage | Incidence | Dose-Response Relationship, Drug | Young Adult | Pyridones - administration & dosage | Time Factors | Aged, 80 and over | Adult | Female | Renal Insufficiency - complications | Stroke - epidemiology | Retrospective Studies | Vitamin K | Stroke - prevention & control | Hemorrhage - epidemiology | Administration, Oral | Atrial Fibrillation - drug therapy | Atrial Fibrillation - complications | Treatment Outcome | Pyrazoles - administration & dosage | Stroke - etiology | Adolescent | Aged | Hemorrhage - chemically induced | Stroke (Disease) | Medical policy | Care and treatment | Atrial fibrillation | Health care industry | Anticoagulants (Medicine) | Kidney diseases | Medical research | Chronic kidney failure | Medicine, Experimental | Heart | Cardiac arrhythmia | Renal function | Embolisms | Indication | Impairment | Risk | Data bases | Bleeding | Training | Prevention | Confidence intervals | Fibrillation | Databases | Ischemia | Safety | Drug dosages | Anticoagulants | Dosing | Stroke | Statistical analysis | Regression | Hazards | Labels | Marking | Patients | Embolism | Disease prevention | Oral cavity | Renal failure | Clinical medicine | Kidney transplantation | Index Medicus | Abridged Index Medicus
Journal Article
American Heart Journal, ISSN 0002-8703, 2017, Volume 190, pp. 12 - 18
Background Oral anticoagulation prevents ischemic strokes in patients with atrial fibrillation. Early detection of atrial fibrillation and subsequent... 
Cardiovascular | FIBRILLATION | CARDIAC & CARDIOVASCULAR SYSTEMS | STROKE PREVENTION | WARFARIN | CLINICAL-IMPLICATIONS | AMERICAN-COLLEGE | CARDIAC MONITOR | RISK | OPEN-LABEL | TEMPORAL RELATIONSHIP | ISCHEMIC-STROKE | Prospective Studies | Follow-Up Studies | Humans | Male | Thiazoles - administration & dosage | Atrial Fibrillation - physiopathology | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Incidence | Time Factors | Female | Stroke - epidemiology | Vitamin K | Heart Rate | Stroke - prevention & control | Pyridines - administration & dosage | Survival Rate - trends | Double-Blind Method | Administration, Oral | Atrial Fibrillation - drug therapy | Risk Factors | Europe - epidemiology | Treatment Outcome | Disease-Free Survival | Stroke - etiology | Atrial Fibrillation - epidemiology | Aged | Fibrinolytic Agents - administration & dosage | Stroke (Disease) | Care and treatment | Anticoagulants (Medicine) | Stroke patients | Atrial fibrillation | Cardiac patients | Implants, Artificial | Prosthesis | Anticoagulants | Therapy | Cardiac arrhythmia | Surgical implants | Aspirin | Stroke | Coagulation | Strokes | Patients | Bleeding | Risk factors | Vitamins | Artifacts | Fibrillation | Ischemia | Defibrillators | Pacemakers | Safety engineering | Electrocardiography | Heart diseases | Index Medicus | Abridged Index Medicus | Trial Design
Journal Article